Bharat Biotech starts phase III trials for Covaxin; will it be world's cheapest vaccine?
Bharat Biotech on Monday started the commencement of phase III trials of the Covaxin, COVID-19 vaccine.
Nov 16, 2020, 18:51 PM IST
COVID-19 vaccine: Odisha's SUM hospital soon to begin Phase 3 human trial of Covaxin
Notably, IMS and SUM Hospital are in the list of 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.
Oct 26, 2020, 08:00 AM IST
India’s coronavirus vaccine, COVAXIN's trials on animals successful, says Bharat Biotech
COVAXIN is one of the front runners in the race for a coronavirus vaccine in India.
Sep 12, 2020, 13:41 PM IST
COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials
The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.
Jun 30, 2020, 21:46 PM IST
